Dr. Budenz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
130 Mason Farm Rd
5151 Bioinformatics
Chapel Hill, NC 27517
Summary
- Dr. Donald Budenz is an ophthalmologist in Chapel Hill, NC and is affiliated with multiple hospitals in the area, including University of North Carolina Hospitals, Chatham Hospital, and Person Memorial Hospital. He received his medical degree from Harvard Medical School and has been in practice 30 years. He specializes in cataract related and glaucoma related and is experienced in cataracts, clinical research, public speaking, and glaucoma.
Clinical Expertise
- Cataracts, Glaucoma, Public speaking, Clinical research, Gonioscopy, Trabeculectomy, Visual field testing, Ocular hypertension, Vision disorders, Ophthalmic Imaging, Cataract And Anterior Segment
Education & Training
- Johns Hopkins Bloomberg School of Public HealthMPH, Epidemiology and International Health, 2002 - 2004
- University of Miami Hospital and ClinicsFellowship, Glaucoma, 1991 - 1992
- University of Pennsylvania Health System/Scheie Eye InstituteResidency, Ophthalmology, 1988 - 1991
- Main Line Health System/Lankenau Medical CenterInternship, Internal Medicine, 1987 - 1988
- Harvard Medical SchoolClass of 1987
- University of PennsylvaniaB.A., 1982
Certifications & Licensure
- NC State Medical License 2011 - 2025
- FL State Medical License 1994 - 2024
- PA State Medical License 1988 - 2018
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- President Association of University Professor of Ophthalmology, 2023-2024
- Life Achievement Award American Academy of Ophthalmology, 2022
- America's Top Doctors Castle Connolly, 2008-2021
- Join now to see all
Clinical Trials
- Ahmed Versus Baerveldt Comparison Study Start of enrollment: 2005 Nov 01
- Macular Ganglion Cell Analysis (GCA) of the Cirrus HD-OCT in Glaucoma Start of enrollment: 2010 Nov 01
- Incidence and Progression of Glaucoma in the Tema Eye Survey Cohort Start of enrollment: 2014 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 1730 citationsGlobal Causes of Blindness and Distance Vision Impairment 1990-2020: A Systematic Review and Meta-AnalysisSeth Flaxman, Rupert R A Bourne, Serge Resnikoff, Peter Ackland, Tasanee Braithwaite
The Lancet. Global Health. 2017-12-01 - 23 citationsAssociation of a Primary Open-Angle Glaucoma Genetic Risk Score With Earlier Age at Diagnosis.Baojian Fan, Jessica N. Cooke Bailey, Robert P. Igo, Jae H. Kang, Tahani Boumenna
JAMA Ophthalmology. 2019-10-01 - 936 citationsMagnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysisRupert R A Bourne, Seth Flaxman, Tasanee Braithwaite, Maria V Cicinelli, Aditi Das
The Lancet. Global Health. 2017-09-01
Journal Articles
- Postoperative Complications in the Ahmed Baerveldt Comparison Study During Five Years of Follow-upBudenz DL, Feuer WJ, Barton K, Schiffman J, Costa VP, Godfrey DG, Buys YM; Ahmed Baerveldt Comparison Study Group, American Journal of Ophthalmology, 1/1/2016
- Effect of adjusting retinal nerve fiber layer profile to fovea-disc angle axis on the thickness and glaucoma diagnostic performanceMwanza, JC, Lee, G, Budenz, DL, American Journal of Ophthalmology, 1/1/2016
- Optical coherence tomography platforms and parameters for glaucoma diagnosis and progressionMwanza JC, Budenz DL, Current Opinion in Ophthalmology, 1/1/2016
- Join now to see all
Books/Book Chapters
Lectures
- Ophthalmic Imaging 2016: Optical Coherent Tomography (OCT) Applications and Future TechnologyPalm Beach, FL - 1/5/2015
- Glaucoma 2014: Battle on the Beach RevisitedMiami, FL - 1/25/2014
- The Essential of Ocular Imaging Course version 3.0Durham, NC - 1/24/2014
- Join now to see all
Press Mentions
- Nicox Appoints Robert N. Weinreb, M.D. And Sanjay G. Asrani, M.D. To Its Glaucoma Clinical Advisory BoardJuly 12th, 2021
- Top Line Results from Glaucoma Dolomites Phase 2 Trial Show Nicox's NCX 470 Meets Primary Endpoint and Demonstrates Statistical Superiority vs LatanoprostOctober 1st, 2019
- Nicox Establishes High-Profile Glaucoma Clinical Advisory BoardMay 6th, 2019
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: